Publication:
Thailand consensus on Helicobacter pylori treatment 2015

dc.contributor.authorVarocha Mahachaien_US
dc.contributor.authorRatha Korn Vilaichoneen_US
dc.contributor.authorRapat Pittayanonen_US
dc.contributor.authorJarin Rojborwonwitayaen_US
dc.contributor.authorSomchai Leelakusolvongen_US
dc.contributor.authorChomsri Kositchaiwaten_US
dc.contributor.authorPisaln Mairiangen_US
dc.contributor.authorOng Ard Praisontarangkulen_US
dc.contributor.authorBuncha Ovartlarnpornen_US
dc.contributor.authorJaksin Sottisupornen_US
dc.contributor.authorPises Pisespongsaen_US
dc.contributor.authorMonthira Maneerattanapornen_US
dc.contributor.authorRavin Sonyen_US
dc.contributor.authorSiam Sirinthornpunyaen_US
dc.contributor.authorOrawan Chaiyamahapurken_US
dc.contributor.authorOlarn Wiwattanachangen_US
dc.contributor.authorInchaya Sansaken_US
dc.contributor.authorPiyathida Harnsomboonen_US
dc.contributor.authorTaned Chitapanaruxen_US
dc.contributor.authorSurapon Chuenrattanakulen_US
dc.contributor.otherChulalongkorn Universityen_US
dc.contributor.otherThammasat University Hospitalen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherKhon Kaen Universityen_US
dc.contributor.otherChiang Mai Universityen_US
dc.contributor.otherNKC institute of Gastroenterology and Hepatologyen_US
dc.contributor.otherLampang Hospitalen_US
dc.contributor.otherRajavithi Hospitalen_US
dc.contributor.otherBuddhachinaraj Hospitalen_US
dc.contributor.otherUdonthani Hospitalen_US
dc.contributor.otherPhramongkutklao College of Medicineen_US
dc.contributor.otherNational Gastric Cancer and Gastrointestinal Diseases Research Centeren_US
dc.date.accessioned2018-12-11T02:15:17Z
dc.date.accessioned2019-03-14T08:04:05Z
dc.date.available2018-12-11T02:15:17Z
dc.date.available2019-03-14T08:04:05Z
dc.date.issued2016-06-01en_US
dc.description.abstractManagement of Helicobacter pylori infection is an important aspect of many upper gastrointestinal tract diseases, such as chronic gastritis, peptic ulcer disease, gastric cancer and mucosa-associated lymphoid tissue (MALT) lymphoma. The Thailand Consensus on H. pylori treatment 2015 consisted of 22 national experts who took active roles, discussed all important clinical information and investigated clinical aspects in four workshops, focuising on: (1) Diagnosis (2) Treatment (3) Follow-up after eradication and (4) H. pylori infection and special conditions. Experts were invited to participate on the basis of their expertise and contribution to H. pylori works and/or consensus methodology. The results of each workshop were taken to a final consensus vote by all experts. Recommendations were developed from the best evidence and availability to guide clinicians in management of this specific infection associated with variety of clinical outcomes.en_US
dc.identifier.citationAsian Pacific Journal of Cancer Prevention. Vol.17, No.5 (2016), 2351-2360en_US
dc.identifier.doi10.7314/APJCP.2016.17.5.2351en_US
dc.identifier.issn2476762Xen_US
dc.identifier.issn15137368en_US
dc.identifier.other2-s2.0-84974625929en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/43027
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84974625929&origin=inwarden_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.titleThailand consensus on Helicobacter pylori treatment 2015en_US
dc.typeReviewen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84974625929&origin=inwarden_US

Files

Collections